1. Home
  2. NTZ vs HOWL Comparison

NTZ vs HOWL Comparison

Compare NTZ & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natuzzi S.p.A.

NTZ

Natuzzi S.p.A.

N/A

Current Price

$3.00

Market Cap

34.3M

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.66

Market Cap

30.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTZ
HOWL
Founded
1959
2017
Country
Italy
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
30.7M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
NTZ
HOWL
Price
$3.00
$0.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.00
AVG Volume (30 Days)
2.5K
287.9K
Earning Date
04-13-2023
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.15
$0.53
52 Week High
$4.46
$2.23

Technical Indicators

Market Signals
Indicator
NTZ
HOWL
Relative Strength Index (RSI) 49.46 36.21
Support Level $2.59 $0.56
Resistance Level $3.17 $0.72
Average True Range (ATR) 0.20 0.07
MACD -0.01 -0.03
Stochastic Oscillator 71.98 0.00

Price Performance

Historical Comparison
NTZ
HOWL

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: